Skip to content

Inhibrx Biosciences, Inc. INBX Income Taxes Paid, Net

Income Taxes Paid, Net at other companies

Replimune Group logo
Replimune GroupREPL
$105K+40.0%
Pfizer logo
PfizerPFE
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Revenue--100%
Operating income-$30.9M+27.9%
Net income-$33.4M+22.8%
EPS (diluted)-$2.15+23.2%

Balance sheet

See full
Cash & equivalents$161.7M-25.3%
Total debt$180.9M+69.8%
Total equity-$21.0M-122%
Total assets$184.0M-24.2%

Cash flow

See full
Operating cash flow-$38.0M-5.9%
CapEx--100%
Free cash flow-$38.0M-5.9%

Valuation

See full
Market cap$1.4B+546%
Enterprise value$1.42B+1,233%
P/S1,073.7×-280×

Profitability

See full
Operating margin-10,386.5%-5,025pp
Net margin-10,773.5%-878,492pp
FCF margin-9,986.5%-4,727pp

Returns & leverage

See full
Return on equity-197.8%-2,158pp
Debt / equity13.4×+13.3×
Current ratio6.5×+1.3×

Where this comes from

Reported directly by Inhibrx Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inhibrx Biosciences, Inc.'s income taxes paid, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inhibrx Biosciences, Inc.'s income taxes paid, net?
Inhibrx Biosciences, Inc. (INBX) reported income taxes paid, net of $0 in Q1 2026.
What does income taxes paid, net mean?
This represents the actual cash outflow for income taxes during the period, net of any refunds received. Unlike the income tax expense reported on the income statement, this figure reflects the timing of actual tax payments to government authorities. It is a key indicator of the company's effective cash tax rate and its ability to manage tax liabilities.